skip navigation
NIH Record  
Vol. LXII, No. 17
  August 20, 2010
Guttmacher Appointed Director Of NICHD
NIH’ers Respond Generously to Food, Household Item Campaign
2010 Bluebird Count Down from Last 2 Years, Virus May Be Culprit
'Adventure in Science' Program Plans 18th Year
printer friendly version
Can We Get a Gold in Green?
Final Part of Bldg. 35, ‘Porter II’ Nears Groundbreaking
  Construction is nearly set to begin on Porter II.
  Construction is nearly set to begin on Porter II.

Construction is nearly set to begin on the second phase of NIH’s on-campus neuroscience facility, the Porter Neuroscience Research Center. PNRC II, construction of which was made possible by American Recovery and Reinvestment Act (ARRA) funds NIH received in 2009, is currently in a site-preparation phase that includes awarding of various building contracts. Groundbreaking could begin as soon as late summer or early fall this year.

Initially, Porter II was going to cost about $266 million of the total $500 million in ARRA funds that NIH was allotted for buildings and facilities. Several months ago, however, NIH received word that construction bids were coming in significantly lower than previously estimated.

Harvard’s Daley Updates NIH on iPS Cells

There are probably only a handful of scientists whose visit to campus in the arid offseason of the Wednesday Afternoon Lecture Series, which normally takes July and August off, could draw a crowd. Harvard stem cell research authority Dr. George Q. Daley is one of them.

The WALS folks dreamed up a midsummer, Monday afternoon version of the lecture on July 26 and, by 3 p.m., Masur Auditorium was packed with curious summer interns and a modest legion of tenured investigators who were either back from, or had not yet gone on, vacation.

Daley, a professor of hematology and director of the stem cell transplantation program at Children’s Hospital Boston, did not disappoint. His résumé alone pointed to a man who could speak authoritatively about the future of 21st century medicine: summa cum laude graduate of Harvard Medical School (only the 12th person to win that honor, in 1991), graduate work with Nobel laureate Dr. David Baltimore, HHMI investigator, member of the NIH Director’s Pioneer Awards inaugural class in 2004, A-list quote supplier when stem cells are a topic in any major newspaper, among many other honors.